Sources Sought: Anti-Carfentanil monoclonal antibody (mAb)

The U.S. Army Medical Research Acquisition Activity (USAMRAA) is issuing this sources sought notice (SSN) on behalf of the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) as a means of conducting market research to identify parties having an interest in and the resources to support the requirement for Anti-Carfentanil monoclonal antibody (mAb) for use in Non-Human Primates.

Based on the responses to this sources sought notice, this requirement may be set-aside for small business (in full or in part) or procured through full and open competition. All small business set-aside categories will be considered. Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions.

PLEASE SEE THE ATTACHED SOURCES SOUGHT NOTICE